Cochrane Abstracts
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Human Thyrotropin (rhTSH) Aided Radioiodine Treatment for Residual or Metastatic Differentiated Thyroid Cancer: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432279/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_residual_or_metastatic_differentiated_thyroid_cancer:_Cochrane_systematic_review.
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432279/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_residual_or_metastatic_differentiated_thyroid_cancer:_Cochrane_systematic_review. Accessed January 13, 2025.
Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer: Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432279/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_residual_or_metastatic_differentiated_thyroid_cancer:_Cochrane_systematic_review
Recombinant Human Thyrotropin (rhTSH) Aided Radioiodine Treatment for Residual or Metastatic Differentiated Thyroid Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2025 January 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432279/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_residual_or_metastatic_differentiated_thyroid_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for residual or metastatic differentiated thyroid cancer: Cochrane systematic review
ID - 432279
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432279/all/Recombinant_human_thyrotropin__rhTSH__aided_radioiodine_treatment_for_residual_or_metastatic_differentiated_thyroid_cancer:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
